| Literature DB >> 31614741 |
Timo Iden1, Amke Caliebe2, Jochen Renner3, Maj-Britt Hertz4, Jan Höcker5, Päivi Suvanto-Scholz6, Markus Steinfath7, Norbert Weiler8, Matthias Gruenewald9.
Abstract
Extended postoperative care and intensive care unit capacity is limited and efficient patient allocation is mandatory. This study aims to develop an effective yet simple score to predict indication for extended postoperative care, as there is a lack of objective criteria for early prediction of admission to extended care in surgical patients. This prospective observational study was divided into two periods (Period 1: Extended Postoperative Care-Score (EXPO)-Score generation; Period 2: EXPO-Score validation) and it was performed at a tertiary university center in Germany. A total of 4042 (Period 1) and 2198 (Period 2) adult patients ≥ 18 years old receiving elective or emergency surgery were included in this study. After identifying patient- and surgery-related risk factors by an expert panel, the EXPO-Score was developed through logistic regression from data of Period 1 and validated in Period 2. Three risk factors are sufficient for generating a reliable predictive EXPO-Score: (1) the American Society of Anesthesiologists' (ASA) physical status, (2) cardiopulmonary physical exercise status expressed in metabolic equivalents (MET), and (3) the type of surgery. The score threshold (0.23) has a sensitivity of 0.87, a specificity of 0.91, and an accuracy of 0.90 for predicting indication for extended postoperative care. The EXPO-Score provides a validated, early collectable, and easy-to-use tool for predicting indication of extended postoperative care in adult surgical patients.Entities:
Keywords: ICU Bed Shortage; Intensive Care Unit; extended postoperative care; objective allocation; patient pathway; patient safety; risk score
Year: 2019 PMID: 31614741 PMCID: PMC6832365 DOI: 10.3390/jcm8101666
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Indications for postoperative Intensive Care Unit (ICU) (primary outcome).
| Indications for ICU Admission |
|---|
| Hemodynamic instability (e.g., vasopressor therapy) |
| Respiratory instability (e.g., re-intubation) |
| Massive intraoperative bleeding/transfusion |
| New severe cardiac arrhythmia (e.g., ventricular tachycardia) |
| Severe pre-existing disease (e.g., myasthenia, ejection fraction < 25%) |
| Surgery-related risk factor (e.g., liver transplantation) |
| Altered consciousness (e.g., delirium) |
| Hypothermia (body core temperature <36° Celsius) |
| High nursing care effort needed (e.g., immobility) |
| Other |
n absolute frequencies observed in Period 1 (multiple indications possible).
Clinical comorbidities deemed important for risk stratification.
| Clinical Comorbidities |
|---|
| Cardiovascular (e.g., heart failure NYHA III-IV) |
| Pulmonary (e.g., COPD) |
| Liver cirrhosis/insufficiency (e.g., GOT/GPT > 2 × normal value) |
| Renal failure (e.g., creatinine > 200 µmol/L) |
| Neurologic disorders (e.g., stroke) |
| Sepsis/infection |
| Isolation/infection prevention (e.g., MRSA) |
| Endocrinopathy (e.g., complex diabetes mellitus) |
NYHA New York Heart Association; COPD Chronic Obstructive Pulmonary Disease; GOT Glutamyl Oxaloacetic Transaminase; GPT Glutamyl Pyruvic Transaminase; MRSA Methicillin Resistant Staphylococcus Aureus; ICU Intensive Care Unit.
Patient characteristics and risk factors.
| Characteristics & | With | No | |
|---|---|---|---|
|
| <0.001 | ||
| Men | 556 (26.8) | 1519 (73.2) | |
| Women | 310 (15.8) | 1657 (84.2) | |
| <0.001 | |||
| <50 | 94 (7.4) | 1179 (92.6) | |
| 50–59 | 124 (18.3) | 555 (81.7) | |
| 60–69 | 210 (26.4) | 584 (73.6) | |
| 70–79 | 298 (31.9) | 635 (68.1) | |
| 80–89 | 124 (37.3) | 208 (62.7) | |
| >90 | 16 (51.6) | 15 (48.4) | |
| 26 (23–30) | 26 (23–30) | 0.49 | |
|
| <0.001 | ||
| I | 13 (1.9) | 662 (98.1) | |
| II | 90 (5.1) | 1660 (94.9) | |
| III | 592 (41.7) | 828 (58.3) | |
| IV | 171 (86.8) | 26 (13.2) | |
|
| <0.001 | ||
| Elective | 659 (19.2) | 2769 (80.8) | |
| N0 | 51 (61.4) | 32 (38.6) | |
| N1 | 53 (47.3) | 59 (52.7) | |
| N2 | 63 (27.2) | 169 (72.8) | |
| N3 | 33 (20.4) | 129 (79.6) | |
|
| |||
| Cardiovascular | 514 (57.7) | 377 (46.3) | <0.001 |
| Pulmonary | 124 (34.8) | 232 (65.2) | <0.001 |
| Liver insufficiency | 24 (66.7) | 12 (33.3) | <0.001 |
| Renal insufficiency | 71 (51.4) | 67 (48.6) | <0.001 |
| Endocrinopathy | 64 (27.2) | 171 (71.8) | 0.033 |
| Neurologic | 112 (45.0) | 137 (55.0) | <0.001 |
| Infection/Sepsis | 32 (69.6) | 14 (30.4) | <0.001 |
| Isolation/Infection (e.g., MRSA) | 29 (70.7) | 12 (29.3) | <0.001 |
| Hemoglobin g/dl (Median [IQR]) | 13 (11–14) | 14 (12–15) | <0.001 |
|
| <0.001 | ||
| ≥4 MET | 486 (14.6) | 2848 (83.4) | |
| <4 MET | 376 (53.7) | 324 (46.3) | |
|
| <0.001 | ||
| Post anesthetic care unit | 48 (1.6) | 2983 (98.4) | |
| Intermediate care unit | 27 (20.5) | 105 (79.5) | |
| Intensive care unit | 781 (91.8) | 70 (8.2) | |
|
| <0.001 | ||
| Thoracic with OLV | 13 (36.1) | 23 (63.9) | |
| Upper abdomen | 25 (37.9) | 41 (62.1) | |
| Hip/knee arthroplasty | 22 (15.7) | 118 (84.3) | |
| Large ENT/maxillofacial tumor | 23 (50.0) | 23 (50.0) | |
| Urogenital | 20 (16.9) | 98 (83.1) | |
| Vascular | 38 (35.2) | 70 (64.8) | |
| Endovascular aortic repair | 30 (75.0) | 10 (25.0) | |
| Cardiac | 300 (99.0) | 3 (1.0) | |
| Non-cardiac with planned ICU | 94 (94.9) | 5 (5.1) | |
| Miscellaneous minor | 94 (4.0) | 2246 (96.0) | |
| Miscellaneous intermediate | 132 (20.5) | 513 (79.5) | |
| Miscellaneous major | 73 (74.5) | 25 (25.5) |
Patient characteristics and potential risk factors for ICU admission during study Period 1. Data are presented as n (% of “with” or “no” ICU indication within stratum) or otherwise indicated. The individual risk factor numbers do not necessarily add up to the total numbers because of occasional missing values. p values are the result of Fisher´s exact (categorical variables) or Wilcoxon rank-sum tests (continuous variables). IQR Interquartile range; N0–N3 emergence categories (target time till skin incision): Immediately (N0), ≤ 2h (N1), ≤ 6h (N2) and ≤ 24h (N3); MET Metabolic equivalents; OLV One-lung ventilation; ENT ear-nose-throat.
Model comparison.
| Statistical | Period 1 | Period 2 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of Variables | |||||||||
| 9 | 7 | 6 | 5 | 4 | 3 | 2 | Grey Zone | 3 | |
|
| 0.91 | 0.90 | 0.91 | 0.87 | 0.89 | 0.91 | 0.88 | 0.91 | 0.92 |
|
| 0.90 | 0.91 | 0.89 | 0.93 | 0.90 | 0.87 | 0.89 | 0.82 | 0.88 |
|
| 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.95 | 0.92 | 0.96 |
| (95% CI) | (0.96–0.97) | (0.96–0.97) | (0.96–0.97) | (0.95–0.97) | (0.95–0.97) | (0.95–0.96) | (0.94–0.96) | (0.91–0.94) | (0.95–0.97) |
|
| 0.91 | 0.90 | 0.91 | 0.88 | 0.89 | 0.90 | 0.88 | 0.83 | 0.91 |
|
| 0.21 | 0.18 | 0.21 | 0.16 | 0.20 | 0.23 | 0.26 | 0.23 | 0.23 |
Comparison of models with different numbers of variables included. The columns with “3 variables” showing data for the selected Extended Postoperative Care-Score (EXPO)-Score model in Period 1 (Score generation) and Period 2 (Score validation). Grey zone analysis excludes surgical categories with planned ICU admission (“cardiac” and “non-cardiac with planned ICU”). AUC Area under the curve; CI Confidence interval.
The final logistic model for the EXPO-Score.
| Variable | Regression | Standard Error | Odds Ratio | |
|---|---|---|---|---|
|
| ||||
| ASA I | Reference | |||
| ASA II | 0.40 | 0.37 | 1.49 | 0.27 |
| ASA III | 2.32 | 0.36 | 10.18 | <0.001 |
| ASA IV | 4.56 | 0.43 | 95.58 | <0.001 |
|
| ||||
| ≥4 MET | Reference | |||
| <4 MET | 1.26 | 0.15 | 3.53 | <0.001 |
|
| ||||
| Miscellaneous minor | Reference | |||
| Miscellaneous intermediate | 1.78 | 0.18 | 5.93 | <0.001 |
| Miscellaneous major | 4.37 | 0.31 | 79.04 | <0.001 |
| Vascular | 1.20 | 0.27 | 3.32 | <0.001 |
| Hip/knee arthroplasty | 1.27 | 0.30 | 3.56 | <0.001 |
| Urogenital | 1.61 | 0.31 | 5.00 | <0.001 |
| Thoracic with OLV | 2.32 | 0.41 | 10.18 | <0.001 |
| Upper abdomen | 2.95 | 0.33 | 19.11 | <0.001 |
| Endovascular aortic repair | 3.51 | 0.43 | 33.45 | <0.001 |
| Large ENT/maxillofacial tumor | 3.83 | 0.37 | 46.06 | <0.001 |
| Non-cardiac with planned ICU | 6.79 | 0.50 | 888.91 | <0.001 |
| Cardiac | 7.11 | 0.60 | 1224.15 | <0.001 |
Final logistic model developed in Period 1 for the three selected variables (i) ASA status, (ii) physical exercise status and (iii) conducted surgery included in the EXPO-Score. The intercept for the regression model is −5.14 with a standard error of 0.35.
Figure 1Receiver operating characteristic (ROC) curve Period 1 vs. Period 2.